Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design

Journal of Clinical Psychopharmacology

Volumn 16, Issue 4, 1996, Pages 294-298

  Hertzberg, Michael A ^a,b   Feldman, Michelle E ^b   Beckham, Jean C ^a,b   Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRAZODONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REM SLEEP; SINGLE BLIND PROCEDURE; SLEEP; SLEEP DISORDER; SOCIAL STATUS;

ADULT; COMBAT DISORDERS; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TRAZODONE; VETERANS;

EID: 0030016407     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199608000-00004     Document Type: Article

References (37)

1. Davidson JRT, Fairbank JA. The epidemiology of posttraumatic stress disorder. In: Davidson JRT, Foa EB, eds. Posttraumatic stress disorder DSM-IV and beyond. Washington, DC: American Psychiatric Press, 1992:147-72.
2. Fairbank JA, Schienger WE, Caddell JM, Woods MG. Posttraumatic stress disorder. In: Sutker PB, Adams HE, eds. Comprehensive handbook of psychopathology. New York: Plenum Press, 1993:145-65.
3. Kessler RB, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the national comorbidity study. Arch Gen Psychiatry 1995;5:1048-60.
4. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:294-305.
5. Davidson J. Drug therapy of posttraumatic stress disorder. Br J Psychiatry 1992;160:309-14.
6. Solomon SD, Gerrity DT, Muff AM. Efficacy of treatments for posttraumatic stress disorder. JAMA 1992;268:633-8.
7. Lipper S, Davidson JRT, Grady TA, Edinger JD, Hammett EB, Mahorney SL, Cavenar JO. Preliminary study of carbamazepine in posttraumatic stress disorder. Psychosomatics 1986;27: 849-54.
8. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55:517-22.
9. Davidson J, Roth S, Newman E. Fluoxetine in posttraumatic stress disorder. J Traumatic Stress 1991;4:419-25.
10. Mine NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder. Am J Psychiatry 1994;151:621.
11. den Boer M, Op den Velde W, Fager PJR, Hovens JE, De Groen JHM, Diujn HV. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom 1992;57:158-63.
12. Nagy LM, Morgan CA, Southwick SM, Charney DS. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993;13:107-13.
13. Marek GJ, McDougle CJ, Price LH, Seiden LS. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology 1992; 109:2-11.
14. Beasley CM, Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 1991;52:294-9.
15. Mellman TA, Kulick-Bell R, Ashlock LE, Nolan B. Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry 1995;1:110-5.
16. Lebert F, Pasquier F, Petit H. Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatry 55;12:536-8.
17. Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med 1994;330:651-5.
18. Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M. Trazodone for antidepressant-associated insomnia Am J Psychiatry 1994;151:1069-72.
19. Kaplan HI, Sadock BJ. Pocket handbook of psychiatrie drug treatment. Baltimore: Williams & Wilkens, 1993:178-80.
20. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry 1994;55:34-9.
21. Margrave R. Serotonergic agents in the management of dementia and posttraumatic stress disorder. Psychosomatics 1993;34:461-2.
22. Liebowitz NR, El-Mallakh RS. Trazodone for the treatment of anxiety symptoms in substance abusers. J Clin Psychopharmacol 1989;9:449-51.
23. Menza MA. Withdrawal syndrome in a depressed patient treated with trazodone. Am J Psychiatry 1986;143:1195.
24. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a clinician-administered PTSD scale. J Traumatic Stress 1995;8:75-80.
25. Davidson JRT, Book SW, Colket JT, Tupler LA, Roth S, David D, Hertzberg M, Mellman T, Beckham JC, Smith RD, Davison RM, Katz R, Feldman ME. Assessment of a new self-rating scale for posttraumatic stress disorder. The Davidson Trauma Scale. Psychol Med, in press.
26. Buysse DJ, Reynolds CF III, Monk TH, Beman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument of psychiatric practice and research. Psychiatry Res 1989;28:193-213.
27. Beck AT, Steer RA. The Revised Beck Depression Inventory. San Antonio, TX: Psychological Corporation, 1987.
28. Spielberger CD. Manual of the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983.
29. Guy W. ECDEU assessment manual for psychopharmacology. Publication ADM 76-338. Washington DC: US Department of Health, Education, and Welfare, 1976;DD.207-222.
30. Barlow DH, Hersen M. Single case experimental designs: strategies for studying behavior change. 2nd ed. New York: Pergamon Press, 1984.
31. Keane TM, Fairbank JA, Caddell JM, Zimering RT, Taylor KL, Mora C. Clinical evaluation of a measure to assess combat exposure. J Consult Clin Psychol 1989;1:53-5.
32. Keane TM, Caddell JM, Taylor KL. Mississippi scale for combat-related posttraumatic stress disorder: three studies in reliability and validity. J Consult Clin Psychol 1988;56:75-80.
33. Shay J. Fluoxetine reduces explosiveness and elevates mood of Vietnam combat vets with PTSD. J Traumatic Stress 1992;5: 97-101.
34. Cassidy S, Henry H. Fatal toxicity of antidepressant drugs in overdose. BMJ. 1987;295:1021-4.
35. Spar JE. Plasma trazodone concentrations in elderly depressed inpatients: cardiac effects and short-term efficacy. J Clin Psychopharmacol 1987;7:406-9.
36. Kapur S, Mieczkowski T, Mann J. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992; 268:3441-5.
37. Garrett HM. Redbook 94. Montvale, NJ: Medical Economics Data Inc., 1994:391.